Pseudopolymorphs of 2,6‐diaminopyrimidin‐4‐one and 2‐amino‐6‐methylpyrimidin‐4‐one: one or two tautomers present in the same crystal

The derivatives of pyrimidin‐4‐one can adopt either a 1H‐ or a 3H‐tautomeric form, which affects the hydrogen‐bonding interactions in cocrystals with compounds containing complementary functional groups. In order to study their tautomeric preferences, we crystallized 2,6‐diaminopyrimidin‐4‐one and 2‐amino‐6‐methylpyrimidin‐4‐one. During various crystallization attempts, four structures of 2,6‐diaminopyrimidin‐4‐one were obtained, namely solvent‐free 2,6‐diaminopyrimidin‐4‐one, C₄H₆N₄O, (I), 2,6‐diaminopyrimidin‐4‐one–dimethylformamide–water (3/4/1), C₄H₆N₄O·1.33C₃H₇NO·0.33H₂O, (Ia), 2,6‐diaminopyrimidin‐4‐one dimethylacetamide monosolvate, C₄H₆N₄O·C₄H₉NO, (Ib), and 2,6‐diaminopyrimidin‐4‐one–N‐methylpyrrolidin‐2‐one (3/2), C₄H₆N₄O·1.5C₅H₉NO, (Ic). The 2,6‐diaminopyrimidin‐4‐one molecules exist only as 3H‐tautomers. They form ribbons characterized by R²₂(8) hydrogen‐bonding interactions, which are further connected to form three‐dimensional networks. An intermolecular N—H...N interaction between amine groups is observed only in (I). This might be the reason for the pyramidalization of the amine group. Crystallization experiments on 2‐amino‐6‐methylpyrimidin‐4‐one yielded two isostructural pseudopolymorphs, namely 2‐amino‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐6‐methylpyrimidin‐4(1H)‐one–dimethylacetamide (1/1/1), C₅H₇N₃O·C₅H₇N₃O·C₄H₉NO, (IIa), and 2‐amino‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐6‐methylpyrimidin‐4(1H)‐one–N‐methylpyrrolidin‐2‐one (1/1/1), C₅H₇N₃O·C₅H₇N₃O·C₅H₉NO, (IIb). In both structures, a 1:1 mixture of 1H‐ and 3H‐tautomers is present, which are linked by three hydrogen bonds similar to a Watson–Crick C–G base pair.     

On triazoles XLI [1]. Synthesis of meso‐ionic [1,2,4]triazolo[5,1‐c]thiadiazoles

Type 6 meso‐ionic [1,2,4]triazolo[5,1‐c]thiadiazoles were synthesised by oxidation of the corresponding N‐methyl‐N'‐(substitutedbenzal)‐5‐amino‐3‐substituted‐1,2,4‐triazol‐1‐yl)thiohydrazide ( 3 ) type bases or their [1,2,4]triazolo[5,1‐d][1,2,3,6]tetrazepin‐5‐thion ( 4 ) type ring tautomers. Besides spectroscopical evidence a preparative proof of their structure was also provided. X‐ray diffraction analysis of 3‐methylthio‐6‐morpholino‐1,2,4‐triazolo[5,1‐c]thiadiazole ( 8 ) showed quite unusual bond lengths for the N¹‐S and S‐C³ bonds of the thiadiazole ring proving the meso‐ionic character of these derivatives unequivocally.     

Cocrystallization of two tautomers: 4‐(1‐{[4‐(dimethylamino)benzylidene]hydrazono}ethyl)benzene‐1,3‐diol and 6‐[(E)‐1‐{[4‐(dimethylamino)benzylidene]hydrazino}ethylidene]‐3‐hydroxycyclohexa‐2,4‐dien‐1‐one (1/1)

Two different tautomeric forms of a new Schiff base, C₁₇H₁₉N₃O₂·C₁₇H₁₉N₃O₂, are present in the crystal in a 1:1 ratio, namely the enol–imine form 4‐(1‐{[4‐(dimethylamino)benzylidene]hydrazono}ethyl)benzene‐1,3‐diol and the keto–amine form 6‐[(E)‐1‐{[4‐(dimethylamino)benzylidene]hydrazino}ethylidene]‐3‐hydroxycyclohexa‐2,4‐dien‐1‐one. The tautomers are formed by proton transfer between the hydroxy O atom and the imine N atom and are hydrogen bonded to each other to form a one‐dimensional zigzag chain along the crystallographic b axis via intermolecular hydrogen bonds.     

Two quinazolinones: a ring conformational study

The molecules of (±)‐2‐(4‐methoxyphenyl)‐1‐phenethyl‐2,3‐dihydroquinazolin‐4(1H)‐one, C₂₃H₂₂N₂O₂, (I), and (±)‐2‐(1,3‐benzodioxol‐5‐yl)‐1‐phenethyl‐2,3‐dihydroquinazolin‐4(1H)‐one, C₂₃H₂₀N₂O₃, (II), have T‐shaped forms in the crystal structure. The tetrahydropyrimidine ring in both structures adopts a sofa conformation. Both molecules are linked by N—H...O and C—H...O hydrogen bonds to form sheets built from alternating R₂²(8) and R₄⁴(26) [R₄⁴(24) in (II)] edge‐fused rings. Additionally, the structures are stabilized by extensive C—H...π interactions.     

Synthesis of aryl-functionalized, 1,5-disubstituted 1,2,3-triazoles and derivatives by arylation of zwitterionic ruthenium triazolato complexes

The synthesis of a series of ruthenium 1,5-disubstituted 1,2,3-triazolato complexes, 1,5-disubstituted 1,2,3-triazoles, and a triazolium salt is reported. Treatment of the ruthenium azido complex [Ru]-N₃ ( 1 , [Ru] = (η⁵-C₅H₅)(dppe)Ru, dppe = Ph₂PCH₂CH₂PPh₂) with an excess of ethyl propiolate results in the formation of a mixture of the Z- and E-forms of zwitterionic N(1)-bound N(3)-ethyl acryl-4-carboxylate triazolato complexes [Ru]N₃(CH=CHCO₂Et)C₂H(CO₂) ( Z - 2 ) and ( E - 2 ). The arylation of 2 with aromatic bromides gives a series of cationic N(1)-bound N(3)-ethyl acryl-4-alkoxycarbonyl triazolato complexes {[Ru]N₃(CH=CHCO₂Et)C₂H(CO₂CH₂R)}[Br] ( 3a , R = Ph ; 3b , R = C₆F₅; 3c , R = 4-C₆H₄CN, 3d , R = 2,6-C₆H₃F₂) and the subsequent cleavage of the Ru-N bond of 3a–d gives 1,5-disubstituted 1,2,3-triazoles N₃(CH=CHCO₂Et)C₂H(CO₂CH₂R) ( 4a , R = Ph; 4b , R = C₆F₅; 4c , R = 4-C₆H₄CN; 4d , R = 2,6-C₆H₃F₂) and [Ru]-Br. A 1,2,3-triazolium salt [N₃(CH=CHCO₂Et)(CH₂C₆F₅)C₂H₂][Br] ( 5 ) was formed by transformation of 4b in BrCH₂C₆F₅/chloroform mixture. The structures of Z-3a and Z-5 were confirmed by single-crystal x-ray diffraction analysis and both complexes participate in non-covalent aromatic interactions in the solid-state structures which can be favorable in the binding of DNA/biomolecular targets and have shown great potential in the application of biologically active anticancer drugs.     

Direct determination of tautomerism in purine derivatives by low-temperature NMR spectroscopy

An investigation of the tautomerism of the purine derivatives N,N-dimethyl-N′-(7(9)-H-purin-6-yl)-formamidine 1, 6-chloropurine 3 and 6-methoxy purine 5 at low temperatures by NMR spectroscopy has been carried out. Knowledge of tautomeric equilibria is important for predicting N-alkylation positions, hydrogen-bonding patterns, and interactions with biological targets. In the NMR spectra of 1 and 5 at 213 K we observed two sets of signals, whereas at laboratory temperature there was only a single set of signals, reflecting the time-averaged contribution of both components. Based on characteristic values of ¹³C and ¹⁵N chemical shifts and of vicinal ¹H-¹³C scalar coupling constants, the two components of 1 were determined to be the N7-H (71%) and N9-H (29%) tautomers and those of 5 as the N7-H (18%) and N9-H (82%) tautomers. The investigation of 3 revealed a substantial predominance of the N9-H tautomer without any separation of NMR signals at 213 K.     

The supramolecular architecture of tris(naphthalene‐1,5‐diaminium) bis(5‐aminonaphthalen‐1‐aminium) octakis[hydrogen (5‐carboxypyridin‐3‐yl)phosphonate]

The asymmetric unit of the title compound, 3C₁₀H₁₂N₂²⁺·2C₁₀H₁₁N₂⁺·8C₆H₅NO₅P⁻, contains one and a half naphthalene‐1,5‐diaminium cations, in which the half‐molecule has inversion symmetry, one 5‐aminonaphthalen‐1‐aminium cation and four hydrogen (5‐carboxypyridin‐3‐yl)phosphonate anions. The crystal structure is layered and consists of hydrogen‐bonded anionic monolayers between which the cations are arranged. The acid monoanions are organized into one‐dimensional chains along the [101] direction via hydrogen bonds established between the phosphonate sites. (C)O—H...N_py hydrogen bonds (py is pyridine) crosslink the chains to form an undulating (010) monolayer. The cations serve both to balance the charge of the anionic network and to connect neighbouring layers via multiple hydrogen bonds to form a three‐dimensional supramolecular architecture.     

Solid‐State and Solution Structural Studies of 4‐{[C(E)]‐1H‐Azol‐1‐ylimino)methyl}pyridin‐3‐ols

The new N‐salicylideneheteroarenamines 1 – 4 were prepared by reacting the biologically relevant 3‐hydroxy‐4‐pyridinecarboxaldehyde ( 5 ) with 1H‐imidazol‐1‐amine ( 6 ), 1H‐pyrazol‐1‐amine ( 7 ), 1H‐1,2,4‐triazol‐1‐amine ( 8 ), and 1H‐1,3,4‐triazol‐1‐amine ( 9 ). Solution ¹H‐, ¹³C‐, and ¹⁵N‐NMR were used to establish that the hydroxyimino form A is the predominant tautomer. A combination of ¹³C‐ and ¹⁵N‐CPMAS‐NMR with X‐ray crystallographic studies confirms that the same form is present in the solid state. The stabilities and H‐bond geometries of the different forms, tautomers and rotamers, are discussed by using B3LYP/6‐31G** calculations.     

Intramolecular Hydrogen Bonding In N-(2-Amino-2-Deoxy-β-D-Glucopyranoside)-N'-Carbamoyl-L-Dipeptidylesters: An Infrared And 1H Nmr Study

ABSTRACT

Ten N-(2-amino-2-deoxy-β-D-glucopyranoside)-N'-carbamoyl-L-dipeptidylesters with different amino acid sequences in the dipeptide unit were studied by means of IR and ¹H NMR spectroscopy. In the IR spectra three bands at 3453, 3420 and 3390 cm^-1 were observed which could be assigned to the free NH, the intramolecularly hydrogen bonded NH species forming five-membered, C₅, and seven-membered, C₇, rings, respectively. Comparing the NH band positions which correspond to the C₇ rings of the Gly-Xaa and the Xaa-Gly dipeptidylesters, the signals of the Xaa-Gly sequence were shifted by 10 cm^-1 to lower wave numbers indicating stronger hydrogen bonds. The temperature effect dv/dT was an order of magnitude larger for the C₇ associates than for C₅ showing the highest enthalpy of the C₇ hydrogen bond. The ¹H NMR spectra give three separate signals for the NH groups. The temperature coefficient ?δ/?T was the largest for N-1-H indicating the formation of less stable hydrogen bonds (C₇). The solvent induced changes of the chemical shift of the NH signals was lowest for the N-3-H signal. Obviously the deshielding properties on this function do not vary in dependence of the solvent polarity. The hydrogen/deuterium exchange rate was lowest for the N-6-H proton indicating the lower accessibility of this proton. Combining the results of both spectroscopic methods it can be concluded that the N-1-H forms only C₇ rings whereas N-6-H can participate in C₅ and C₇ intramolecular hydrogen bonds. The strength of the formed C₇ associates depends on the amino acid sequence in the dipeptide residue.     

A structural hierarchy in the hydrogen‐bonded adduct N,N′‐di­methyl­piperazine–tartaric acid–water (1/2/2): an N‐component N‐dimensional structure (N = 3) with substructures having N = 1 and 2

In the hydrated adduct N,N′‐di­methyl­piperazine‐1,4‐diium bis(3‐carboxy‐2,3‐di­hydroxy­propanoate) dihydrate, [MeNH(CH₂CH₂)₂NHMe]²⁺·2(C₄H₅O₆)^?·2H₂O or C₆H₁₆N₂²⁺·2C₄H₅O₆^?·2H₂O, formed between racemic tartaric acid and N,N′‐di­methyl­piperazine (triclinic P, Z′ = 0.5), the cations lie across centres of inversion. The anions alone form chains, and anions and water mol­ecules together form sheets; the sheets are linked by the cations to form a pillared‐layer framework. The supramolecular architecture thus takes the form of a family of N‐dimensional N‐component structures having N = 1, 2 or 3.     

3‐Cyano‐6‐hydroxy‐4‐methyl‐2‐pyridone: two new pseudopolymorphs and two cocrystals with products of an in situ nucleophilic aromatic substitution

Four crystal structures of 3‐cyano‐6‐hydroxy‐4‐methyl‐2‐pyridone (CMP), viz. the dimethyl sulfoxide monosolvate, C₇H₆N₂O₂·C₂H₆OS, (1), the N,N‐dimethylacetamide monosolvate, C₇H₆N₂O₂·C₄H₉NO, (2), a cocrystal with 2‐amino‐4‐dimethylamino‐6‐methylpyrimidine (as the salt 2‐amino‐4‐dimethylamino‐6‐methylpyrimidin‐1‐ium 5‐cyano‐4‐methyl‐6‐oxo‐1,6‐dihydropyridin‐2‐olate), C₇H₁₃N₄⁺·C₇H₅N₂O₂⁻, (3), and a cocrystal with N,N‐dimethylacetamide and 4,6‐diamino‐2‐dimethylamino‐1,3,5‐triazine [as the solvated salt 2,6‐diamino‐4‐dimethylamino‐1,3,5‐triazin‐1‐ium 5‐cyano‐4‐methyl‐6‐oxo‐1,6‐dihydropyridin‐2‐olate–N,N‐dimethylacetamide (1/1)], C₅H₁₁N₆⁺·C₇H₅N₂O₂⁻·C₄H₉NO, (4), are reported. Solvates (1) and (2) both contain the hydroxy group in a para position with respect to the cyano group of CMP, acting as a hydrogen‐bond donor and leading to rather similar packing motifs. In cocrystals (3) and (4), hydrolysis of the solvent molecules occurs and an in situ nucleophilic aromatic substitution of a Cl atom with a dimethylamino group has taken place. Within all four structures, an R₂²(8) N—H...O hydrogen‐bonding pattern is observed, connecting the CMP molecules, but the pattern differs depending on which O atom participates in the motif, either the ortho or para O atom with respect to the cyano group. Solvents and coformers are attached to these arrangements via single‐point O—H...O interactions in (1) and (2) or by additional R₄⁴(16) hydrogen‐bonding patterns in (3) and (4). Since the in situ nucleophilic aromatic substitution of the coformers occurs, the possible Watson–Crick C–G base‐pair‐like arrangement is inhibited, yet the cyano group of the CMP molecules participates in hydrogen bonds with their coformers, influencing the crystal packing to form chains.     

Supramolecular hydrogen‐bonding patterns in two cocrystals of the N(7)–H tautomeric form of N6‐benzoyladenine: N6‐benzoyladenine–3‐hydroxypyridinium‐2‐carboxylate (1/1) and N6‐benzoyladenine–DL‐tartaric acid (1/1)

Two novel cocrystals of the N(7)—H tautomeric form of N⁶‐benzoyladenine (BA), namely N⁶‐benzoyladenine–3‐hydroxypyridinium‐2‐carboxylate (3HPA) (1/1), C₁₂H₉N₅O·C₆H₅NO₃, (I), and N⁶‐benzoyladenine–DL‐tartaric acid (TA) (1/1), C₁₂H₉N₅O·C₄H₆O₆, (II), are reported. In both cocrystals, the N⁶‐benzoyladenine molecule exists as the N(7)—H tautomer, and this tautomeric form is stabilized by intramolecular N—H...O hydrogen bonding between the benzoyl C=O group and the N(7)—H hydrogen on the Hoogsteen site of the purine ring, forming an S(7) motif. The dihedral angle between the adenine and phenyl planes is 0.94 (8)° in (I) and 9.77 (8)° in (II). In (I), the Watson–Crick face of BA (N6—H and N1; purine numbering) interacts with the carboxylate and phenol groups of 3HPA through N—H...O and O—H...N hydrogen bonds, generating a ring‐motif heterosynthon [graph set R₂²(6)]. However, in (II), the Hoogsteen face of BA (benzoyl O atom and N7; purine numbering) interacts with TA (hydroxy and carbonyl O atoms) through N—H...O and O—H...O hydrogen bonds, generating a different heterosynthon [graph set R₂²(4)]. Both crystal structures are further stabilized by π–π stacking interactions.     

Quinone chemistry. Synthesis and tautomerism of 4,7-indazolequinones

The reaction of 1 with hydrazines provided hydrazinium-4,7-dioxo-4,7-dihydroindazol-3-olates 2a-e and 4,7-indazolequinones 3f,g depending upon the nature of the substituent present in the reactants. Compounds 3a-g were obtained by treatment of 2a-e with sodium hydroxide. Fixed tautomers 4a-b and 5c-f were synthesized by methylation of the corresponding 3a-f or 2a-2e with diazomethane. Migration of a methyl group of 5c-f from the oxygen at C₃ to N₁ on heating afforded 6c-f . The tautomerism of 2a-e and 3a-g has been studied by comparing ir, uv, ¹H nmr and ¹³C nmr spectra with those of the fixed tautomers.     

1H, 13C and 15N NMR spectroscopic,x‐ray structural and ab initio/HF studies on nitramino and N‐alkylamino‐4‐nitro derivatives of pyridine N‐oxides and pyridines

The ¹H, ¹³C and ¹⁵N NMR spectra in DMSO‐d₆ were measured for eight nitraminopyridine N‐oxides, ten 4‐nitropyridine N‐oxides, four 2‐nitraminopyridines and five 4‐nitropyridines. Their chemical shift assignments are based on PFG ¹H,X (X = ¹³C and ¹⁵N) HMQC and HMBC experiments. The relative energies for the tautomers of two nitraminopyridine N‐oxides were determined by ab initio HF/6–311G** calculations. A single‐crystal x‐ray structural analysis was made for 4‐methyl‐2‐nitraminopyridine: C₆H₇O₂N₃, M = 153.15, triclinic, space group P‐1 (No. 2), a = 7.0275(4), b = 6.8034(3), c = 8.6086(5) Å, α = 103.620(2), β = 90.309(2), γ = 122.215(3)°, V = 334.11(3) ų, Z = 2. Copyright © 2003 John Wiley & Sons, Ltd.     

Cocrystals of 6‐methyl‐2‐thiouracil: presence of the acceptor–donor–acceptor/donor–acceptor–donor synthon

The results of seven cocrystallization experiments of the antithyroid drug 6‐methyl‐2‐thiouracil (MTU), C₅H₆N₂OS, with 2,4‐diaminopyrimidine, 2,4,6‐triaminopyrimidine and 6‐amino‐3H‐isocytosine (viz. 2,6‐diamino‐3H‐pyrimidin‐4‐one) are reported. MTU features an ADA (A = acceptor and D = donor) hydrogen‐bonding site, while the three coformers show complementary DAD hydrogen‐bonding sites and therefore should be capable of forming an ADA/DAD N—H...O/N—H...N/N—H...S synthon with MTU. The experiments yielded one cocrystal and six cocrystal solvates, namely 6‐methyl‐2‐thiouracil–2,4‐diaminopyrimidine–1‐methylpyrrolidin‐2‐one (1/1/2), C₅H₆N₂OS·C₄H₆N₄·2C₅H₉NO, (I), 6‐methyl‐2‐thiouracil–2,4‐diaminopyrimidine (1/1), C₅H₆N₂OS·C₄H₆N₄, (II), 6‐methyl‐2‐thiouracil–2,4‐diaminopyrimidine–N,N‐dimethylacetamide (2/1/2), 2C₅H₆N₂OS·C₄H₆N₄·2C₄H₉NO, (III), 6‐methyl‐2‐thiouracil–2,4‐diaminopyrimidine–N,N‐dimethylformamide (2/1/2), C₅H₆N₂OS·0.5C₄H₆N₄·C₃H₇NO, (IV), 2,4,6‐triaminopyrimidinium 6‐methyl‐2‐thiouracilate–6‐methyl‐2‐thiouracil–N,N‐dimethylformamide (1/1/2), C₄H₈N₅⁺·C₅H₅N₂OS⁻·C₅H₆N₂OS·2C₃H₇NO, (V), 6‐methyl‐2‐thiouracil–6‐amino‐3H‐isocytosine–N,N‐dimethylformamide (1/1/1), C₅H₆N₂OS·C₄H₆N₄O·C₃H₇NO, (VI), and 6‐methyl‐2‐thiouracil–6‐amino‐3H‐isocytosine–dimethyl sulfoxide (1/1/1), C₅H₆N₂OS·C₄H₆N₄O·C₂H₆OS, (VII). Whereas in cocrystal (I) an R₂²(8) interaction similar to the Watson–Crick adenine/uracil base pair is formed and a two‐dimensional hydrogen‐bonding network is observed, the cocrystals (II)–(VII) contain the triply hydrogen‐bonded ADA/DAD N—H...O/N—H...N/N—H...S synthon and show a one‐dimensional hydrogen‐bonding network. Although 2,4‐diaminopyrimidine possesses only one DAD hydrogen‐bonding site, it is, due to orientational disorder, triply connected to two MTU molecules in (III) and (IV).     

Reduced 3,4′‐bipyrazoles from a simple pyrazole precursor: synthetic sequence,molecular structures and supramolecular assembly

The reaction of 5‐chloro‐3‐methyl‐1‐phenyl‐1H‐pyrazole‐4‐carbaldehyde and N‐benzylmethylamine under microwave irradiation gives 5‐[benzyl(methyl)amino]‐3‐methyl‐1‐phenyl‐1H‐pyrazole‐4‐carbaldehyde, C₁₉H₁₉N₃O, (I). Subsequent reactions under basic conditions, between (I) and a range of acetophenones, yield the corresponding chalcones. These undergo cyclocondensation reactions with hydrazine to produce reduced bipyrazoles which can be N‐formylated with formic acid or N‐acetylated with acetic anhydride. The structures of (I) and of representative examples from this reaction sequence are reported, namely the chalcone (E )‐3‐{5‐[benzyl(methyl)amino]‐3‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl}‐1‐(4‐bromophenyl)prop‐2‐en‐1‐one, C₂₇H₂₄BrN₃O, (II), the N‐formyl derivative (3RS )‐5′‐[benzyl(methyl)amino]‐3′‐methyl‐1′,5‐diphenyl‐3,4‐dihydro‐1′H ,2H‐[3,4′‐bipyrazole]‐2‐carbaldehyde, C₂₈H₂₇N₅O, (III), and the N‐acetyl derivative (3RS )‐2‐acetyl‐5′‐[benzyl(methyl)amino]‐5‐(4‐methoxyphenyl)‐3′‐methyl‐1′‐phenyl‐3,4‐dihydro‐1′H ,2H‐[3,4′‐bipyrazole], which crystallizes as the ethanol 0.945‐solvate, C₃₀H₃₁N₅O₂·0.945C₂H₆O, (IV). There is significant delocalization of charge from the benzyl(methyl)amino substituent onto the carbonyl group in (I), but not in (II). In each of (III) and (IV), the reduced pyrazole ring is modestly puckered into an envelope conformation. The molecules of (I) are linked by a combination of C—H…N and C—H…π(arene) hydrogen bonds to form a simple chain of rings; those of (III) are linked by a combination of C—H…O and C—H…N hydrogen bonds to form sheets of R ²₂(8) and R ⁶₆(42) rings, and those of (IV) are linked by a combination of O—H…N and C—H…O hydrogen bonds to form a ribbon of edge‐fused R ²₄(16) and R ⁴₄(24) rings.     

Molecular structure of 6-methyluracil in the gas phase and characteristics of the 6-methyluracil-water system

Geometric parameters of the 6-methyluracil molecule were determined by gas-phase electron diffraction: interatomic distances (r _a, Å) N¹-C² 1.390(3), C²-N³ 1.384(3), N³-C⁴ 1.407(3), C⁴-C⁵ 1.455(10), C⁵-C⁶ 1.336(20), C¹-C⁶ 1.395(3), C-Me 1.519(5); bond angles (deg) N¹C²N³ 114.1(), C²N³C⁴ 126.3(7), N³C⁴C⁵ 114.3(5), C⁴C⁵C⁶ 121.6(5), C⁵C⁶C¹ 119.7(5), C⁷C⁶C⁵ 11C⁵.4(8), O⁸C²N¹ 123.5(1.5), O⁹C⁴N³ 123.3(10). The heterocycle is planar. One of the C-H bonds of the methyl group and the C⁵=C⁶ bond are coplanar. The nearest surrounding of the heterocycle by water molecules (four and five molecules) was examined by AM1 and B3LYP/6-31G** calculations, and the energies of the hydrogen bonds in the heterocycle-water system were estimated.     

Supramolecular hydrogen‐bonded networks in cytosinium nicotinate monohydrate and cytosinium isonicotinate cytosine dihydrate

The title compounds are proton‐transfer compounds of cytosine with nicotinic acid [systematic name: 4‐amino‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium nicotinate monohydrate (cytosinium nicotinate hydrate), C₄H₆N₃O⁺·C₆H₄NO₂⁻·H₂O, (I)] and isonicotinic acid [systematic name: 4‐amino‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium isonicotinate–4‐aminopyrimidin‐2(1H)‐one–water (1/1/2) (cytosinium isonicotinate cytosine dihydrate), C₄H₆N₃O⁺·C₆H₄NO₂⁻·C₄H₅N₃O·2H₂O, (II)]. In (I), the cation and anion are interlinked by N—H...O hydrogen bonding to form a one‐dimensional tape. These tapes are linked through water molecules to form discrete double sheets. In (II), the cytosinium–cytosine base pairs are connected by triple hydrogen bonds, leading to one‐dimensional polymeric ribbons. These ribbons are further interconnected via nicotinate–water and water–water hydrogen bonding, resulting in an overall three‐dimensional network.     

13C-NMR study on the tautomerism of 3-(arylhydrazono)methyl-2-oxo-1,2-dihydroquinoxalines between the hydrazone imine and diazenylenamine forms

The ¹³C-nmr study was carried out for the tautomerism of the 3-(arylhydrazono)methyl-2-oxo-1,2-dihy-droquinoxalines 1a-g and 2a-e between the hydrazone imine A and diazenylenamine B forms, providing the carbon chemical shifts for the tautomers A and B of compounds 1a-g and 2a-e. The comparison of the carbon chemical shifts for the tautomer B of compounds 1d, 1f , and 2b in deuteriodimethyl sulfoxide with those in deuteriotrifluoroacetic acid showed that the C_4a, C₅, and diazenyl carbons were considerably shielded presumably due to the azo N-deuteration in deuteriotrifluoroacetic acid.     

6‐Chloroisocytosine and 5‐bromo‐6‐methylisocytosine: again,one or two tautomers present in the same crystal?

It is well known that pyrimidin‐4‐one derivatives are able to adopt either the 1H‐ or the 3H‐tautomeric form in (co)crystals, depending on the coformer. As part of ongoing research to investigate the preferred hydrogen‐bonding patterns of active pharmaceutical ingredients and their model systems, 2‐amino‐6‐chloropyrimidin‐4‐one and 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4‐one have been cocrystallized with several coformers and with each other. Since Cl and Br atoms both have versatile possibilities to interact with the coformers, such as via hydrogen or halogen bonds, their behaviour within the crystal packing was also of interest. The experiments yielded five crystal structures, namely 2‐aminopyridin‐1‐ium 2‐amino‐6‐chloro‐4‐oxo‐4H‐pyrimidin‐3‐ide–2‐amino‐6‐chloropyrimidin‐4(3H)‐one (1/3), C₅H₇N₂⁺·C₄H₃ClN₃O⁻·3C₄H₄ClN₃O, (Ia), 2‐aminopyridin‐1‐ium 2‐amino‐6‐chloro‐4‐oxo‐4H‐pyrimidin‐3‐ide–2‐amino‐6‐chloropyrimidin‐4(3H)‐one–2‐aminopyridine (2/10/1), 2C₅H₇N₂⁺·2C₄H₃ClN₃O⁻·10C₄H₄ClN₃O·C₅H₆N₂, (Ib), the solvent‐free cocrystal 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(1H)‐one (1/1), C₅H₆BrN₃O·C₅H₆BrN₃O, (II), the solvate 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(1H)‐one–N‐methylpyrrolidin‐2‐one (1/1/1), C₅H₆BrN₃O·C₅H₆BrN₃O·C₅H₉NO, (III), and the partial cocrystal 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(1H)‐one–2‐amino‐6‐chloropyrimidin‐4(3H)‐one (0.635/1/0.365), C₅H₆BrN₃O·C₅H₆BrN₃O·C₄H₄ClN₃O, (IV). All five structures show R₂²(8) hydrogen‐bond‐based patterns, either by synthon 2 or by synthon 3, which are related to the Watson–Crick base pairs.